Suchergebnisse - "AMP-Activated Protein Kinase Kinases"

PubPharm (2.203)

1

Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer : a comprehensive study based on meta-analyses and bioinformatics analyses

enthalten in: BMC cancer | 2024

von Xu, K. | Lu, W. | Yu, A. | +2

2

Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort

enthalten in: Tumori | 2024

von Olsen, A. | Lebedeva, A. | Nosova, P. | +5

3

STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Baptiste Oudart, J. | Garinet, S. | Leger, C. | +11

4

Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Sun, L. | Handorf, E. | Zhou, Y. | +3

5

The AMPK-related kinase NUAK1 controls cortical axons branching by locally modulating mitochondrial metabolic functions

enthalten in: Nature communications | 2024

von Lanfranchi, M. | Yandiev, S. | Meyer-Dilhet, G. | +17

6

Ovarian Mucinous Tumor Presenting Atypical Lobular Endocervical Glandular Hyperplasia-Like Appearance in a Patient With Germline STK11 p.F354L Variant : A Case Report

enthalten in: International journal of surgical pathology | 2024

von Yoshida, H. | Hiranuma, K. | Nakahara, M. | +6

7

Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer

enthalten in: JCO precision oncology | 2024

von Naqash, A. | Floudas, C. | Aber, E. | +21

8

Carnosic Acid against Lung Cancer : Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling

enthalten in: International journal of molecular sciences | 2024

von O'Neill, E. | Sze, N. | MacPherson, R. | +1

9

Redoxhigh phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma

enthalten in: Oncoimmunology | 2024

von Wei, X. | Lu, C. | Zhang, Y. | +17

10

STK11 loss leads to YAP1-mediated transcriptional activation in human KRAS-driven lung adenocarcinoma cell lines

enthalten in: Cancer gene therapy | 2024

von Lenahan, S. | Sarausky, H. | Deming, P. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[221]